Covalon Technologies Ltd. (CVE:COV - Get Free Report) hit a new 52-week high during trading on Friday . The stock traded as high as C$3.58 and last traded at C$3.57, with a volume of 28386 shares changing hands. The stock had previously closed at C$3.44.
Covalon Technologies Trading Up 4.7 %
The firm has a market cap of C$98.64 million, a P/E ratio of -86.00 and a beta of 0.64. The company has a 50 day moving average of C$3.24 and a 200 day moving average of C$2.39. The company has a debt-to-equity ratio of 4.98, a quick ratio of 6.45 and a current ratio of 5.24.
Covalon Technologies (CVE:COV - Get Free Report) last announced its earnings results on Wednesday, August 21st. The company reported C$0.06 earnings per share (EPS) for the quarter. The firm had revenue of C$9.22 million during the quarter. Covalon Technologies had a negative return on equity of 3.85% and a negative net margin of 2.82%. Analysts predict that Covalon Technologies Ltd. will post 0.3 EPS for the current fiscal year.
Covalon Technologies Company Profile
(
Get Free Report)
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Covalon Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Covalon Technologies wasn't on the list.
While Covalon Technologies currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
